80 related articles for article (PubMed ID: 19171142)
1. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P
Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142
[TBL] [Abstract][Full Text] [Related]
2. Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion.
Szebeni GJ; Kriston-Pál É; Blazsó P; Katona RL; Novák J; Szabó E; Czibula Á; Fajka-Boja R; Hegyi B; Uher F; Krenács L; Joó G; Monostori É
PLoS One; 2012; 7(7):e41372. PubMed ID: 22844466
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review.
Aderinto N; Abdulbasit MO; Olatunji D; Edun M
Ann Med Surg (Lond); 2023 Nov; 85(11):5557-5567. PubMed ID: 37915694
[TBL] [Abstract][Full Text] [Related]
4. Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.
Martínez-Bosch N; Fernández-Barrena MG; Moreno M; Ortiz-Zapater E; Munné-Collado J; Iglesias M; André S; Gabius HJ; Hwang RF; Poirier F; Navas C; Guerra C; Fernández-Zapico ME; Navarro P
Cancer Res; 2014 Jul; 74(13):3512-24. PubMed ID: 24812270
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities.
Bogut A; Stojanovic B; Jovanovic M; Dimitrijevic Stojanovic M; Gajovic N; Stojanovic BS; Balovic G; Jovanovic M; Lazovic A; Mirovic M; Jurisevic M; Jovanovic I; Mladenovic V
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958483
[TBL] [Abstract][Full Text] [Related]
7. CD44s-activated tPA/LRP1-NFκB pathway drives lamellipodia outgrowth in luminal-type breast cancer cells.
Qiu Y; Wang H; Guo Q; Liu Y; He Y; Zhang G; Yang C; Du Y; Gao F
Front Cell Dev Biol; 2023; 11():1224827. PubMed ID: 37842093
[TBL] [Abstract][Full Text] [Related]
8. Galectin functions in cancer-associated inflammation and thrombosis.
Kruk L; Braun A; Cosset E; Gudermann T; Mammadova-Bach E
Front Cardiovasc Med; 2023; 10():1052959. PubMed ID: 36873388
[TBL] [Abstract][Full Text] [Related]
9. Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Bannoud N; Stupirski JC; Cagnoni AJ; Hockl PF; Pérez Sáez JM; García PA; Mahmoud YD; Gambarte Tudela J; Scheidegger MA; Marshall A; Corrie PG; Middleton MR; Mariño KV; Girotti MR; Croci DO; Rabinovich GA
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2214350120. PubMed ID: 36634146
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.
Zhao X; Li H; Lyu S; Zhai J; Ji Z; Zhang Z; Zhang X; Liu Z; Wang H; Xu J; Fan H; Kou J; Li L; Lang R; He Q
Int J Biol Sci; 2021; 17(10):2590-2605. PubMed ID: 34326696
[TBL] [Abstract][Full Text] [Related]
11. Activated fibroblasts enhance cancer cell migration by microvesicles-mediated transfer of Galectin-1.
Toti A; Santi A; Pardella E; Nesi I; Tomasini R; Mello T; Paoli P; Caselli A; Cirri P
J Cell Commun Signal; 2021 Sep; 15(3):405-419. PubMed ID: 34021474
[TBL] [Abstract][Full Text] [Related]
12. The Multifaceted Role of Plasminogen in Cancer.
Heissig B; Salama Y; Osada T; Okumura K; Hattori K
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669052
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes.
Xu T; Xu X; Liu PC; Mao H; Ju S
Front Oncol; 2020; 10():563527. PubMed ID: 33251135
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer detection via Galectin-1-targeted Thermoacoustic Imaging: validation in an
Qin H; Qin B; Yuan C; Chen Q; Xing D
Theranostics; 2020; 10(20):9172-9185. PubMed ID: 32802185
[No Abstract] [Full Text] [Related]
15. The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer.
Manero-Rupérez N; Martínez-Bosch N; Barranco LE; Visa L; Navarro P
Cells; 2020 Mar; 9(3):. PubMed ID: 32168866
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling.
You X; Liu Q; Wu J; Wang Y; Dai J; Chen D; Zhou Y; Lian Y
J Cancer; 2019; 10(25):6286-6297. PubMed ID: 31772662
[No Abstract] [Full Text] [Related]
17. Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker.
Martinez-Bosch N; Barranco LE; Orozco CA; Moreno M; Visa L; Iglesias M; Oldfield L; Neoptolemos JP; Greenhalf W; Earl J; Carrato A; Costello E; Navarro P
Oncotarget; 2018 Aug; 9(68):32984-32996. PubMed ID: 30250644
[TBL] [Abstract][Full Text] [Related]
18. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
19. PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway.
Tang D; Zhang J; Yuan Z; Zhang H; Chong Y; Huang Y; Wang J; Xiong Q; Wang S; Wu Q; Tian Y; Lu Y; Ge X; Shen W; Wang D
Oncotarget; 2017 Oct; 8(49):86488-86502. PubMed ID: 29156810
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
